Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy.
Department of Gynecologic Oncology, IRCCS National Cancer Institute, Milan, Italy.
Crit Rev Oncol Hematol. 2019 Nov;143:76-80. doi: 10.1016/j.critrevonc.2019.07.021. Epub 2019 Aug 2.
In the recent years, minimally invasive surgery has emerged as the gold standard for the treatment of both benign and malignant gynecological conditions. Growing evidence suggest that laparoscopic and robotic-assisted treatments allow to archived the same long-term outcomes than conventional open abdominal treatments, minimizing peri-operative morbidity. In the present review we analyzed the advances in the treatment of cervical cancer patients, reporting the advances in both the evolution of concept of radical hysterectomy and of the adoption of minimally invasive surgery. We discussed the advantages related to the introduction of minimally invasive treatment for cervical cancer patients; innovation of conventional laparoscopic surgery as discussed as well. Recent evidence suggested a potential detrimental effect on long-term survival outcomes related to the use of minimally invasive surgery in patients affected by cervical cancer. However, reasons why minimally invasive surgery might have a detrimental effect are still unclear. Further evidence is needed in order to improve quality of treatment for cervical cancer patients.
近年来，微创外科已成为治疗良性和恶性妇科疾病的金标准。越来越多的证据表明，腹腔镜和机器人辅助治疗可以达到与传统开腹治疗相同的长期效果，同时最大限度地减少围手术期发病率。在本综述中，我们分析了宫颈癌患者治疗方面的进展，报告了根治性子宫切除术概念的演变和微创治疗的应用方面的进展。我们讨论了引入微创治疗宫颈癌患者的相关优势；也讨论了传统腹腔镜手术的创新。最近的证据表明，微创治疗宫颈癌患者可能对长期生存结果产生不利影响。然而，微创治疗可能产生不利影响的原因尚不清楚。为了提高宫颈癌患者的治疗质量，还需要更多的证据。
